PTC Therapeutics (PTCT) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
PTC Therapeutics (PTCT) PT Lowered to $30 at RBC Capital
May 10, 2018 8:51 AM EDTRBC Capital lowered its price target on PTC Therapeutics (NASDAQ: PTCT) to $30.00 (from $31.00) while maintaining a Sector Perform rating.
... More


